Your daily source for trading strategies, tech news, and politically incorrect humor.
Hey there, Bullets Fans –
Your Morning Bullets Brief Updates are here! And that means trivia is, too.
On this day in 1930, what happened to the Bank of the United States?
Think you know the answer? You can check it in the closing area down below!
Image Source: Morning Bullets
The FDA has said it “notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution,” indicating that the official approval of Pfizer’s vaccine is on the way.
However, investors seem more focused this morning on the stimulus talks and the lack of any real movement on that front. The House adjourned until next week and the Senate Majority Leader indicated that Republicans were probably not going to vote for the bipartisan bill worth $908 billion.
The Dow Jones Industrial Average reflected that uncertainty this morning, as it was poised for a 150-point loss at open.
Other Top Financial News
It’s time for trades that win both ways
Image Source: Reuters
Members of a Food and Drug Administration advisory panel voted 17-4 to recommend approval of Pfizer’s vaccine. Yesterday’s much-anticipated meeting of the Vaccines and Related Biological Products Advisory Committee marks the final step before the FDA decides whether to grant emergency use authorization of the drug.
That final stamp of approval could even come today, an expert says.
It remains unclear how the vaccine impacts pregnant women and children, and individuals in those demographic groups may have to wait longer to receive the vaccine.
Pfizer’s CEO, Albert Bourla, said of yesterday’s meeting: “If the FDA issues an authorization, stand at the ready to bring this vaccine to people in the U.S. in an effort to help combat this devastating pandemic.”
Market Movers & Predictions